Baker Brothers Advisors - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 194 filers reported holding HERON THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$8,375,628
-11.2%
8,131,6780.0%0.05%
-12.7%
Q2 2023$9,432,746
-23.2%
8,131,6780.0%0.06%
-17.9%
Q1 2023$12,278,834
-39.6%
8,131,6780.0%0.07%
-45.1%
Q4 2022$20,329,195
-40.8%
8,131,6780.0%0.12%
-45.8%
Q3 2022$34,316,000
+51.3%
8,131,6780.0%0.22%
+74.4%
Q2 2022$22,687,000
-51.2%
8,131,6780.0%0.13%
-51.7%
Q1 2022$46,513,000
-37.3%
8,131,6780.0%0.27%
-26.0%
Q4 2021$74,242,000
-14.6%
8,131,6780.0%0.36%
-5.5%
Q3 2021$86,928,000
-31.1%
8,131,6780.0%0.38%
-31.0%
Q2 2021$126,204,000
+29.9%
8,131,678
+35.6%
0.55%
+31.6%
Q1 2021$97,174,000
-23.4%
5,994,7040.0%0.42%
-11.9%
Q4 2020$126,878,000
+42.8%
5,994,7040.0%0.48%
+34.6%
Q3 2020$88,842,000
+0.4%
5,994,704
-0.4%
0.36%
-9.0%
Q2 2020$88,526,000
+25.3%
6,018,1040.0%0.39%
-10.3%
Q1 2020$70,653,000
-50.0%
6,018,1040.0%0.44%
-42.2%
Q4 2019$141,425,000
+27.0%
6,018,1040.0%0.75%
-0.7%
Q3 2019$111,335,000
-0.5%
6,018,1040.0%0.76%
-0.4%
Q2 2019$111,877,000
-8.8%
6,018,104
+19.9%
0.76%
-3.2%
Q1 2019$122,642,000
-5.8%
5,018,1040.0%0.78%
-26.4%
Q4 2018$130,170,000
-18.2%
5,018,104
-0.1%
1.07%
+1.7%
Q3 2018$159,051,000
-18.5%
5,025,2980.0%1.05%
-28.6%
Q2 2018$195,233,000
+40.8%
5,025,2980.0%1.47%
+24.7%
Q1 2018$138,698,000
+150.4%
5,025,298
+64.2%
1.18%
+145.0%
Q4 2017$55,398,000
+23.0%
3,060,641
+9.8%
0.48%
+31.5%
Q3 2017$45,026,000
+16.8%
2,787,992
+0.2%
0.36%
+8.3%
Q2 2017$38,552,000
-7.7%
2,783,5690.0%0.34%
-1.5%
Q1 2017$41,754,000
+33.7%
2,783,569
+16.8%
0.34%
+11.8%
Q4 2016$31,225,000
-36.6%
2,383,569
-16.6%
0.31%
-31.5%
Q3 2016$49,230,000
-4.5%
2,857,2500.0%0.45%
-17.4%
Q2 2016$51,573,000
-6.6%
2,857,250
-1.7%
0.54%
-7.0%
Q1 2016$55,219,000
-28.9%
2,907,7840.0%0.58%
-9.5%
Q4 2015$77,638,000
+9.4%
2,907,7840.0%0.64%
-2.0%
Q3 2015$70,950,000
-18.9%
2,907,784
+3.6%
0.66%
-14.5%
Q2 2015$87,491,000
+130.6%
2,807,784
+7.7%
0.77%
+142.7%
Q1 2015$37,943,000
+44.6%
2,607,7840.0%0.32%
+17.9%
Q4 2014$26,234,000
+20.8%
2,607,7840.0%0.27%
-2.2%
Q3 2014$21,723,000
-32.4%
2,607,7840.0%0.27%
-30.5%
Q2 2014$32,128,000
+6.5%
2,607,784
+20.3%
0.39%
+2.9%
Q1 2014$30,153,0002,167,7840.38%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
TANG KEVIN C 760$783100.00%
Velan Capital Investment Management LP 6,986,744$7,196,3465.80%
Tejara Capital Ltd 2,109,681$2,172,9711.23%
JW Asset Management, LLC 2,407,418$2,479,6411.07%
Rubric Capital Management LP 26,713,503$27,514,9081.03%
GREAT POINT PARTNERS LLC 4,737,368$4,879,4890.89%
Orchard Capital Management, LLC 2,142,823$2,207,1080.82%
Clearline Capital LP 6,149,842$6,334,3380.54%
CM Management, LLC 450,000$463,5000.49%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 327,450$337,2740.48%
View complete list of HERON THERAPEUTICS INC shareholders